North America Breathalyzers Market Report and Forecast 2024-2032

North America Breathalyzers Market Analysis

A breathalyzer is a device employed to determine the alcohol content in the individual’s system or to detect the presence of an infection or disease. Increased cases of drunk driving and the implementation of stringent government regulations and policies are contributing to the global breathalyzer market expansion. There is a growing adoption of home breathalyzers to check blood alcohol content (BAC) levels quickly and accurately before driving. BACtrack Trace Professional Breathalyzer and AlcoHAWK Ultra Slim Breathalyzer are some popular personal breathalyzers that offer reliable results. Further, manufacturers are increasingly focusing on creating smaller and more portable devices with enhanced user interfaces. The introduction of new breathalyzer models with improved features is expected to drive the North America breathalyzers market growth.

The market is witnessing an increased application of breathalyzers in the healthcare sector. This trend is supported by the rising technological advancements that are improving the precision and performance of these devices to detect disease by analyzing human breath. For instance, scientists from CU Boulder and the National Institute of Standards and Technology (NIST) reported a new laser-based breathalyzer that leverages artificial intelligence (AI) and quantum technology to detect the coronavirus with high accuracy in real time. The results of this Nobel Prize-winning frequency-comb technology-based breathalyzer were published in the Journal of Breath Research in April 2023. The finding reveals the potential breath analysis as a rapid, non-invasive test for COVID-19 and other disease states. The development of such devices that can detect the signature of diseases is likely to revolutionize medical diagnostics and fuel the North America breathalyzers market demand.

One of the major market trends is the rising strategic partnerships to expedite the development of innovative breathalyzer devices. In May 2024, Ombra Group Inc., a global pioneer in gas detection solutions, announced a collaboration with the leading medical organizations to design and conduct clinical trials of its first-ever tetrahydrocannabinol (THC) breathalyzer prototype in Canada. This initiative is in response to global cannabis legalization which prompts the need for a device that can measure THC intoxication. Thus, as the demand for reliable drug testing solutions increases to address the issue of drugged driving, the market value of breathalyzers is anticipated to experience a surge in the coming years.

North America Breathalyzers Market Report Snapshots

North America Breathalyzers Market Size

North America Breathalyzers Market Analysis

North America Breathalyzers Companies